101 results
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
for these purposes accrued but unpaid contributions) exceeds the present value of all benefits accrued or earned or payments due under such plan, agreement … benefits earned or accrued or payments due under such plan, agreement, policy or arrangement determined using reasonable actuarial assumptions.
(aa
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
does not discuss certain tax benefits, including under the Law for Encouragement of Capital Investments, 5719-1959, to which we may become eligible … of the treaty) holding the shares as a capital asset and entitled to claim the benefits afforded to such a resident by the United States-Israel Tax
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
exercise of pre-funded warrants). This summary does not discuss certain tax benefits, including under the Law for Encouragement of Capital Investments, 5719 … is a United States resident (for purposes of the treaty) holding the shares as a capital asset and entitled to claim the benefits afforded
8-K
URGN
UroGen Pharma Ltd
13 Jun 24
Regulation FD Disclosure
10:51am
for UGN-102; the potential for UGN-102 to become the first FDA-approved medicine for LG-IR-NMIBC; the opportunity and potential benefits of UGN-102
8-K
EX-99.1
URGN
UroGen Pharma Ltd
13 Jun 24
Regulation FD Disclosure
10:51am
approved medicine for LG-IR-NMIBC; the opportunity and potential benefits of UGN-102 for LG-IR-NMIBC and potential advantages over TURBT; the potential
8-K
EX-99.1
4ccust 9xal
4 Mar 24
Regulation FD Disclosure
7:00am
8-K
EX-99.1
zvuyi
7 Feb 24
Regulation FD Disclosure
4:15pm